Planned chemotherapy regimens
| Drug . | Administration, method (time) . | Standard BEACOPP doses . | Escalated BEACOPP doses . |
|---|---|---|---|
| Bleomycin | IV (d 8) | IU/m2/d | 10 IU/m2/d |
| Etoposide | IV (d 1-3) | 100 mg/m2/d | 200 mg/m2/d |
| Doxorubicin | IV (d 1) | 25 mg/m2/d | 35 mg/m2/d |
| Cyclophosphamide* | IV (d 1) | 650 mg/m2/d | 1250 mg/m2/d |
| Vincristine† | IV (d 8) | 1.4 mg/m2/d | 1.4 mg/m2/d |
| Procarbazine | PO (d 1-7) | 100 mg/m2/d | 100 mg/m2/d |
| Prednisone | PO (d 1-7) | 40 mg/m2/d | 40 mg/m2/d |
| Drug . | Administration, method (time) . | Standard BEACOPP doses . | Escalated BEACOPP doses . |
|---|---|---|---|
| Bleomycin | IV (d 8) | IU/m2/d | 10 IU/m2/d |
| Etoposide | IV (d 1-3) | 100 mg/m2/d | 200 mg/m2/d |
| Doxorubicin | IV (d 1) | 25 mg/m2/d | 35 mg/m2/d |
| Cyclophosphamide* | IV (d 1) | 650 mg/m2/d | 1250 mg/m2/d |
| Vincristine† | IV (d 8) | 1.4 mg/m2/d | 1.4 mg/m2/d |
| Procarbazine | PO (d 1-7) | 100 mg/m2/d | 100 mg/m2/d |
| Prednisone | PO (d 1-7) | 40 mg/m2/d | 40 mg/m2/d |